BD Board Declares Dividend
FRANKLIN LAKES, N.J., July 22, 2014 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 54.5 cents per common share payable on September 30, 2014 to holders of record on September 9, 2014. The indicated annual dividend rate is $2.18 per share.
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, supporting the management of diabetes and advancing cellular research. We are nearly 30,000 associates in 50 countries who strive to fulfill our purpose of "Helping all people live healthy lives" by advancing the quality, accessibility, safety and affordability of healthcare around the world. For more information, please visit www.bd.com.
Monique N. Dolecki, Investor Relations – 201-847-5378
Alyssa J. Zeff, Corporate Communications – 201-847-4358
SOURCE BD (Becton, Dickinson and Company)